I now have comprehensive data. Let me compile the full clinical answer.
Alcohol Withdrawal - OPD Management & First-Line Treatment
1. First, Assess Severity Using CIWA-Ar Scale
The Clinical Institute Withdrawal Assessment for Alcohol - revised (CIWA-Ar) is the standard tool to guide treatment intensity. It scores 10 items (tremor, sweating, anxiety, agitation, perceptual disturbances, headache, nausea/vomiting, auditory/visual disturbances, orientation) - each 0-7, maximum 67.
| CIWA-Ar Score | Severity | Setting |
|---|
| ≤ 8 | Mild | Home / OPD |
| 9-15 | Moderate | OPD / Community team |
| > 15 | Severe | Hospital |
| > 10 + medical comorbidities | Severe | Hospital admission |
Also assess:
- Time since last drink (withdrawal begins 6-8 h after last drink)
- History of previous seizures or DTs (high-risk - admit)
- Liver disease (affects drug choice)
- Social support (reliable caregiver at home?)
- Nutritional status
2. Outpatient (OPD) Suitability Criteria
A patient can be managed as OPD only if:
- CIWA-Ar ≤ 15 (mild-moderate), no prior seizures/DTs
- No severe medical comorbidities
- Reliable social support and a responsible adult at home
- Patient is motivated and cooperative
- No active suicidal ideation or psychiatric emergency
- Liver function is adequate (or use oxazepam if impaired)
Admit (do NOT manage OPD) if: CIWA-Ar >15, prior DTs or seizure history, severe medical illness, no social support, or signs of Wernicke encephalopathy.
3. First-Line Treatment: Benzodiazepines
Benzodiazepines are the undisputed first-line treatment for alcohol withdrawal. They exhibit cross-tolerance with alcohol (GABA-A agonism), suppress autonomic hyperactivity, prevent seizures, and prevent progression to delirium tremens. This is supported by NICE guidelines, Cochrane systematic review, and British Association for Psychopharmacology guidelines. - Maudsley Prescribing Guidelines in Psychiatry, 15th ed.
Drug of Choice for OPD
Chlordiazepoxide (Librium) - preferred in non-specialist settings (UK/India) due to relatively lower dependence-forming potential, long half-life providing smooth self-tapering.
Diazepam - used in many centres; also long-acting, provides good seizure coverage.
Special cases:
- Liver disease (cirrhosis, hepatic failure): Use Oxazepam 15-30 mg PO q6-8h or Lorazepam - both undergo direct glucuronidation (no hepatic oxidation), safer in liver impairment.
- Elderly / slow metabolizers: Short-acting agents (lorazepam, oxazepam) preferred.
4. OPD Fixed-Dose Reduction Regimen (Standard Protocol)
The fixed-dose reduction method is the most common in non-specialist/OPD settings.
Chlordiazepoxide Fixed-Dose Taper (Maudsley Guidelines)
A general rule: 1 mg chlordiazepoxide per 1 unit of alcohol consumed per day.
| Day | Chlordiazepoxide Dose |
|---|
| Day 1-2 | 30 mg QDS (four times daily) = 120 mg/day |
| Day 3-4 | 20 mg QDS = 80 mg/day |
| Day 5-6 | 10 mg QDS = 40 mg/day |
| Day 7 | 5 mg QDS = 20 mg/day |
| Day 8 | Stop |
- For heavy drinkers (>20 units/day): starting dose up to 40 mg QDS (160 mg/day)
- For mild dependence: start at 10-20 mg QDS
- Maximum dose: 250-300 mg/day
Alternatively: Diazepam 10 mg QDS with taper (reduce by 5 mg every 1-2 days over 7-10 days). - Washington Manual of Medical Therapeutics
Never start the regimen if blood alcohol concentration is still rising. Monitor for oversedation and respiratory depression.
5. Symptom-Triggered Regimen (if CIWA monitoring available at OPD/daily review)
Give benzodiazepine only when CIWA-Ar ≥ 8-10 (on-demand dosing):
- Diazepam 5-10 mg PO or Lorazepam 1-2 mg PO per episode
- Reassess every 1-4 hours
- Advantage: less total drug used, fewer side effects
- Requires trained staff who can score CIWA-Ar reliably
6. Mandatory Adjunctive Treatments
Thiamine (Vitamin B1) - MANDATORY in all patients
Alcoholics are severely B1-depleted. Thiamine must be given before any glucose (to prevent precipitating Wernicke encephalopathy).
| Situation | Route & Dose |
|---|
| Well-nourished, mild withdrawal (OPD) | Oral thiamine 100 mg TDS for 30 days |
| Malnourished / moderate-severe | IM/IV thiamine 100-500 mg before oral supplementation |
| Risk of Wernicke's | Pabrinex IV (high-potency parenteral thiamine) |
Other Supplements
- Multivitamin containing folic acid daily
- Magnesium replacement only if hypomagnesemia confirmed
- Hydration: Oral rehydration; correct electrolytes (K+, Mg2+)
- Diet: Encourage balanced diet as tolerated
7. Seizure Risk - Special Instructions
- History of prior withdrawal seizures → use long-acting benzodiazepine (diazepam/chlordiazepoxide) prophylactically; these significantly reduce de novo seizures (meta-analysis confirmed). - Maudsley Prescribing Guidelines
- Phenytoin is NOT recommended for alcohol withdrawal seizures - does not prevent them and may lower seizure threshold. - Tintinalli's Emergency Medicine
- If a seizure occurs despite adequate benzodiazepine: consider carbamazepine loading. - Maudsley Prescribing Guidelines
- Any first seizure during withdrawal requires investigation to rule out organic disease or idiopathic epilepsy.
8. Progression of Withdrawal Symptoms (Timeline)
| Time After Last Drink | Symptom | Severity |
|---|
| 6-8 hours | Tremulousness, anxiety, nausea, tachycardia | Mild |
| 8-12 hours | Perceptual disturbances (hallucinosis) | Moderate |
| 12-24 hours | Seizures (grand mal) | Severe |
| 48-72 hours | Delirium tremens (DTs) | Life-threatening |
Maudsley: Mild symptoms onset 3-12 h, peak tremor at 24-48 h, duration up to 14 days. - Kaplan & Sadock's Synopsis of Psychiatry
9. Alcohol-Induced Hallucinosis vs DTs
- Alcoholic hallucinosis (8-48 h after cessation): Auditory/visual hallucinations with clear sensorium - NOT DTs. May add low-dose antipsychotic.
- Delirium Tremens (48-96 h): Confusion + agitation + autonomic instability + hallucinations. Mortality 5-15% if untreated. This requires inpatient/ICU management, not OPD.
10. OPD Follow-Up Plan
- Day 2 and Day 5: Review for symptom control, oversedation, compliance
- Check LFTs, CBC, electrolytes, blood glucose on first visit
- Educate patient and caregiver: signs to return to ED (seizure, severe confusion, high fever)
- After acute detox: Refer for relapse prevention (naltrexone, acamprosate, motivational counseling)
Summary Prescription Template (Mild-Moderate OPD Patient)
1. Tab. Chlordiazepoxide 25 mg × 4 times/day (Day 1-2)
25 mg × 3 times/day (Day 3-4)
25 mg × 2 times/day (Day 5-6)
25 mg × 1 time/day (Day 7)
STOP Day 8
[Adjust starting dose based on consumption and CIWA-Ar]
2. Tab. Thiamine (Vit B1) 100 mg × 3 times/day × 30 days
3. Tab. Multivitamin with folic acid × 1 OD × 30 days
4. Oral rehydration / normal diet
5. CIWA-Ar scoring at each visit
6. Review in 2 days. Return immediately if: seizure, confusion, high fever
Sources: Maudsley Prescribing Guidelines in Psychiatry 15th ed. | Kaplan & Sadock's Synopsis of Psychiatry | Washington Manual of Medical Therapeutics | Tintinalli's Emergency Medicine